Controlled document PF-011A
TLO DUO Phase 1 Master Formula
Record identification
- Document ID
- PF-011A
- Document type
- Template
- Status
- Documented
- Source
- Standardisation & Production of SIRIAM Products
Overview
PF-011A
PRODUCT FORMULA CARD
SIRIAM TLO DUO – PHASE 1 (VISCERO-FASCIAL RELEASE)
DOCUMENT CONTROL
Field
Product ID
Formula ID
Document
Product
Anatomical Region
Therapeutic Phase
Product Type
Standard Batch
Version
Status
Internal QR
| Value |
|---|
| SIR-TLO-001 |
| MF-011 |
| PF-011A |
| TLO DUO – Phase 1 |
| T10–L2 |
| Viscero-Fascial Release |
| Topical Magistral Cream |
| 100 g |
| 2.0 |
| 🔒 LOCKED |
| ☐ |
1. PRODUCT PURPOSE
Field
Clinical Objective
Anatomical Region
Primary Biological Target
Therapeutic Phase
Product Type
| Description |
|---|
| Viscero-fascial and neurovegetative modulation |
| T10–L2 |
| Psoas and visceral release with autonomic unloading |
| Phase 1 – Release |
| Topical Magistral Cream |
2. MASTER FORMULA
The ingredient quantities follow the uploaded Phase 1 magistral fiche, with the agreed SQMS standardisation.
| Code |
|---|
| Official Ingredient |
| Supplier |
| Master Qty |
| Unit |
| Phase |
| PC-001 |
| Lanette Cream FNA |
| Fagron |
| 65.00 |
| g |
| B |
| PC-002 |
| Aqua Purificata |
| Fagron |
| 18.00 |
| g |
| W |
| SC-001 |
| Magnesium Chloride |
| Fagron |
| 4.00 |
| g |
| W |
| SC-002 |
| MSM |
| — |
| 2.50 |
| g |
| W |
| OC-001 |
| Castor Oil |
| Natural Heroes |
| 4.00 |
| g |
| L |
| OC-002 |
| Jojoba Oil |
| Natural Heroes |
| 2.00 |
| g |
| L |
| SC-003 |
| D-Panthenol |
| Natural Heroes |
| 0.50 |
| g |
| W |
| SC-004 |
| Vitamin E Full Spectrum |
| Natural Heroes |
| 0.50 |
| g |
| L |
| BE-013 |
| Solidago virgaurea (A.Vogel) |
| A.Vogel |
| 0.70 |
| mL |
| C |
| BE-014 |
| Berberis vulgaris (Aromedica) |
| Aromedica |
| 0.30 |
| mL |
| C |
| BE-009 |
| Ruta graveolens |
| — |
| 0.40 |
| mL |
| C |
| BE-002 |
| Copaiba Oil |
| Aroma-Zone |
| 0.30 |
| mL |
| C |
| SC-005 |
| Silicea Gel (+1 drop Silicea D8) |
| — |
| 1.50 |
| g |
| C |
| CL-001 |
| Sea Buckthorn Oil (optional) |
| — |
| 1 |
| drop |
| C |
| PR-001 |
| Cosgard 221 |
| Aromantic |
| 0.70 |
| g |
| C |
3. MANUFACTURING WORKFLOW
Step
1
2
3
4
5
6
7
8
9
10
Prepared according to the Lanette protocol in the magistral fiche.
| Action |
|---|
| ✓ |
| Verify raw materials |
| □ |
| Prepare water phase |
| □ |
| Prepare oil phase |
| □ |
| Emulsification |
| □ |
| Cool below 40°C |
| □ |
| Add botanical extracts |
| □ |
| Add Copaiba and Silicea Gel (+1 drop Silicea D8) |
| □ |
| Quality Control |
| □ |
| Fill airless dispensers |
| □ |
| Batch Release |
| □ |
4. QUALITY CONTROL
Standard SQMS Quality Control
Appearance
Colour
Odour
Homogeneity
pH (5.2–5.5)
Viscosity
Packaging
Net Weight
5. BATCH RELEASE
Standard SQMS Batch Release
6. CLINICAL APPLICATION
Field
Anatomical Region
Primary Zone
Secondary Zone
Additional Zone
Additional Projection
Frequency
Treatment Phase
Application zones follow the magistral protocol.
| Value |
|---|
| T10–L2 |
| Lower abdomen |
| Flanks |
| Paravertebral T10–L2 |
| Iliac crest |
| 1–2× daily |
| Weeks 1–2 |
Related documents
Platform modules